Abstract
Gaining long-term graft function and patient survival remain a critical challenge following kidney transplantation. Recently, it is reported that microbiota is associated with complications in kidney allograft recipients. Therefore, we conducted a study in a kidney transplant population which aimed to: To describe the epidemiologic characteristics of our population, to identify the factors that could influence the microbiota and to delineate the risk factors associated with microbiota and could affect the allograft outcome We conducted a cross sectional study carried out by the nephrology department in the university hospital of Sousse Sahloul from November 2007 to September 2015. We included in our study patients who received tacrolimus in maintenance therapy. In the absence of the current possibility of direct study of the microbiota we considered that infectious complications requiring the use of several antibiotics were responsible for microbiota change in renal transplant patients. Over the study period, 170 kidney transplant were performed and 81 patients (47%) were included in the study of the total transplanted patients. The average age of the adults was 32.84±9,176 [17 - 55] years while the mean age of the children was 12.95±2.91 [7 - 16] years. The sex ratio was 1.5. The average age of kidney donors was 38.68 ± 10.607 years. Renal transplantation was performed from a cadaveric donor in 4 cases and in 77 cases it was from a living donor. The induction therapy for kidney transplant recipients was based on the antithymocyte immunoglobulin in 60% of cases and the anti-interleukin-2 receptor antibodies in 40 % of cases. The mean initial dose of tacrolimus was 8.52 ± 1.9 mg/d which corresponds to 0,17 ± 0.065 mg/kg/d. Infectious complications were observed in 66 patients (82.7%). Among our patients, 52 patients had urinary tract infection, 23 patients had BK virus infections,16 patients had gastrointestinal infection, 14 patients had cytomegalovirus infection, 6 patients had Candidiasis and 5 patients had a common germ pulmonary infection. In our series, 11 patients (13.6%) presented allograft dysfunction during their follow-up, 5 patients (6.2%) had lost their allograft and 5 patients (6.2%) have died. The comparative analysis revealed that dose weight of tacrolimus at the first year was significantly associated with the infectious complications. In fact, the patients who had infectious complications required higher doses of tacrolimus at first year (p=0.028). We found that patients who had two or more infections were exposed to more risk of allograft rejection (p=0.006). We found that patients who had at least two infections presented an unfavourable outcome (p=0.026). We noted that the antithymocyte immunoglobulin was associated with a higher risk of infections (p=0.035) than basiliximab (p=0.026). Renal transplantation is an effective treatment for an end-stage kidney disease, however, post-transplant complications remain its major challenge. A deeper understanding of the function and composition of microbiota can help clinic to connect the microbiota features with the organ outcomes, including graft survival, inflammation, infection, rejection, alloreactivity and fibrosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.